2-1. Structural Heart Disease [TCTAP A-161] The Association of Cardiac Valve Sclerosis with Clinical Outcomes in Patients Undergoing Endovascular Revascularization for Peripheral Arterial Disease
Abstract Presenter
April 27
4:10 PM - 4:20 PM
Abstract Zone I, Level 3
1-2. Endovascular Intervention [TCTAP A-120] Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Peripheral Arterial Disease Patients Underwent Endovascular Revascularization and Combined with Significant Coronary Artery Disease
CardioVascular Research Foundation(CVRF)
2nd Floor, Asan Institute for Education & Research,
88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Business registration number: 215-82-06387
Copyright ¨Ï 2002 CVRF, Seoul, Korea. All rights reserved.